Login / Signup

Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15.

Tyler B FaustHojong YoonRadosław P NowakKatherine Aleisha DonovanZhengnian LiQuan CaiNicholas A EleuteriTinghu ZhangNathanael S GrayEric S Fischer
Published in: Nature chemical biology (2019)
The investigational drugs E7820, indisulam and tasisulam (aryl-sulfonamides) promote the degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the activity critically depends on the cullin RING ligase substrate receptor DCAF15, the molecular details remain elusive. Here we present the cryo-EM structure of the DDB1-DCAF15-DDA1 core ligase complex bound to RBM39 and E7820 at a resolution of 4.4 Å, together with crystal structures of engineered subcomplexes. We show that DCAF15 adopts a new fold stabilized by DDA1, and that extensive protein-protein contacts between the ligase and substrate mitigate low affinity interactions between aryl-sulfonamides and DCAF15. Our data demonstrate how aryl-sulfonamides neo-functionalize a shallow, non-conserved pocket on DCAF15 to selectively bind and degrade RBM39 and the closely related splicing factor RBM23 without the requirement for a high-affinity ligand, which has broad implications for the de novo discovery of molecular glue degraders.
Keyphrases
  • protein protein
  • small molecule
  • single molecule
  • clinical trial
  • transcription factor
  • high throughput
  • machine learning
  • drug induced
  • binding protein
  • double blind